Filing Details

Accession Number:
0001209191-23-032024
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-05-24 20:15:21
Reporting Period:
2023-05-23
Accepted Time:
2023-05-24 20:15:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534133 Calcimedica Inc. CALC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1484729 Rachel A. Leheny C/O Calcimedica, Inc.
505 Coast S. Blvd. #202
La Jolla CA 92037
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-05-23 3,000 $3.34 4,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 356,989 Indirect By Valence Investments SPV IV, LLC
Common Stock 66,228 Indirect By Valence Investments SPV V, LLC
Common Stock 316,109 Indirect By Valence Investments SPV VI, LLC
Footnotes
  1. The weighted average purchase price for the transaction reported was $3.3439, and the range of prices were between $3.09 and $3.37. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. The Reporting Person, a co-founder and managing director of Valence Investments SPV IV, LLC ("Valence IV"), Valence Investments SPV V, LLC ("Valence V") and Valence Investments SPV VI, LLC (Valence VI), may be deemed to beneficially own the securities held by Valence IV, Valence V and Valence VI (the "Valence Securities"). The Reporting Person disclaims beneficial ownership of the Valence Securities except to the extent of her pecuniary interest therein.